Bio is a pioneering decentralized science protocol established in 2023, dedicated to advancing AI-driven biotech research. The company empowers scientists by providing a platform to raise funds, create value from their research, and directly share that value with their communities. With over $50 million directed to global researchers, Bio offers a transformative alternative to traditional pharmaceutical funding. Supported by notable investors such as Binance Labs, Northpond Ventures, and Animoca Brands, Bio is focused on accelerating the development of real-world therapeutics across various fields, including longevity, brain health, fertility, and psychedelic science.